Sign up to save your podcasts
Or
Share Selecta Biosciences' Dr. Carsten Brunn on Gene Therapy with AAV Vectors
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Selecta Biosciences' Dr. Carsten Brunn on Gene Therapy with AAV Vectors
We love to hear from our listeners. Send us a message.
Selecta Biosciences' President and CEO Dr. Carsten Brunn details the company's ImmTOR platform, which can mitigate unwanted immune responses that cause immune-related toxicities that impose significant treatment challenges with current therapies.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Selecta Biosciences' President and CEO Dr. Carsten Brunn details the company's ImmTOR platform, which can mitigate unwanted immune responses that cause immune-related toxicities that impose significant treatment challenges with current therapies.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
More shows like Cell & Gene: The Podcast
View all
Fareed Zakaria GPS
3,447 Listeners
Nature Podcast
756 Listeners
HBR IdeaCast
154 Listeners
Science Magazine Podcast
818 Listeners
The Daily
113,121 Listeners
Today, Explained
10,331 Listeners
The Readout Loud
337 Listeners
Short Wave
6,592 Listeners
The Prof G Pod with Scott Galloway
5,610 Listeners
Consider This from NPR
6,462 Listeners
Business Of Biotech
85 Listeners
Hard Fork
5,576 Listeners
The Weekly Show with Jon Stewart
11,013 Listeners
ASGCT Podcast Network
16 Listeners
Prof G Markets
1,480 Listeners